Navigation Links
Mayo Clinic researchers use human vaccine to cure prostate cancer in mice
Date:6/19/2011

ROCHESTER, Minn. Mayo Clinic investigators and collaborators from the United Kingdom cured well-established prostate tumors in mice using a human vaccine with no apparent side effects. This novel cancer treatment approach encourages the immune system to rid itself of prostate tumors without assistance from toxic chemotherapies and radiation treatments. Such a treatment model could some day help people to live tumor free with fewer side effects than those experienced from current therapies.

The findings appear in the journal Nature Medicine.

"We are hopeful that this will overcome some of the major hurdles which we have seen with immunotherapy cancer research," says Richard Vile, Ph.D., Mayo Clinic immunologist, Richard M. Schulze Family Foundation Professor and a lead author of the study. Clinical trials could begin within two years.

Mayo's immunotherapy research led by Dr. Vile already shows promise in treating prostate cancer and melanoma. It also is a prime candidate for treatment of many more aggressive cancers, such as lung, brain and pancreatic cancer.

Among the team's findings: no trace of autoimmune diseases in the mice. The murine T-cells attacked only cancerous prostate cells, leaving the healthy tissue unharmed.

To develop this new approach, geneticists assembled snippets of genetic code from healthy human prostate tissue into a complementary DNA (cDNA) library. These bits of cDNA were then inserted into a swarm of vesicular stomatitis viruses (VSV), which were cultured and reintroduced into the test mice as a vaccine during a series of intravenous injections.

Development of comprehensive cDNA libraries from healthy human prostate tissue represents the key to successful immunotherapy. All infections, allergens and tissues, including tumors, have a unique fingerprint called an antigen a molecular protein tag that triggers a response from the body's immune system. Dr. Vile deployed the h
'/>"/>

Contact: Bob Nellis
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Neuralstem updates clinical trial progress
2. 1-stop clinic ups mental health, social work visits for veterans
3. Bone cancer, from the lab to the clinic
4. Universal flu vaccine clinical trials show promise
5. Mayo Clinic: Flaxseed no cure for hot flashes during breast cancer or menopause
6. Pioneering stem cell bandage receives approval for clinical trial
7. Fighting cancer with cancer: Mayo Clinic finds promising use for thyroid cancer gene
8. Mayo Clinic, NCCTG find no tie between PTEN and response to breast cancer drug
9. Mayo Clinic: Raoul Tibes, M.D., Ph.D., to receive Career Development Award
10. In the lab and clinic, VCU Massey develops a new therapy for blood cancers
11. Mayo Clinic finds discussion of end-of-life care helps heart to patients and families
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Rock, AR (PRWEB) May 27, 2015 ... Medix today announce a partnership to provide CMSA's ... Medix community. This collaboration seeks to strengthen the ... measurement through CMSA’s CKP program. The mutually beneficial ... on identifying individual skills of talent in the ...
(Date:5/27/2015)... Mountain View, CA (PRWEB) May 27, 2015 ... Napa Valley will be able to reach for Organic Coconut ... 2015. Coco Libre will be available at VIP areas, artist ... will also be available at area hotels and on festival ... as a partner this year,” said Noa Elan, Director of ...
(Date:5/27/2015)... Meadows, IL (PRWEB) May 27, 2015 ... release of its SonarMD Platform, a first-of-its ... monitoring and managing patients with chronic gastrointestinal ... Kosinski, MD, MBA, the application allows physicians ... visits through the ongoing use of electronic ...
(Date:5/27/2015)... 27, 2015 SmarterSkin, http://www.smarterskindermatology.com , is ... cutting-edge test that makes it easier for patients to find ... , Dr. Sejal Shah is a cosmetic dermatologist based ... to offer the test. This revolutionary DNA test uses 16 ... skin aging: , 1. Firmness and elasticity , ...
(Date:5/27/2015)... CRN International, the radio marketing and promotions ... Financial Officer. , Prinner most recently was Principal of ... financial/operational executive positions at telecom and technology services companies ... and SNET. His accounting and consulting career began ... will be able to tap into his experience of ...
Breaking Medicine News(10 mins):Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2Health News:SonarMD™, LLC, Launches Game-Changing, IBD Population Health Management Platform 2Health News:SmarterSkin Dermatology is Now Offering Skin DNA Analysis 2Health News:CRN International Names New Chief Financial Officer 2
... ... ... continuing to offer H1N1 nasal vaccines and H1N1 vaccine shots at four Centegra Primary Care (CPC) ... sites in Huntley, Woodstock, Crystal Lake and McHenry and will be open as follows: , ...
... , LA JOLLA, Calif., Dec. 3 ... Studies unanimously voted to elect three new members during its ... is co-founder and Managing Director of De Novo Ventures in Palo ... in early stage medical device and biotechnology companies. Dotzler founded Medicus ...
... , Research could lead to an ... known to result in cancer and genetic diseases , ... first time observed the movement of a single molecule of ... significantly, they have identified a previously unknown step that they ...
... primates , , THURSDAY, Dec. 3 (HealthDay News) -- A ... a primate study. , The drug, called SPC3649, uses a ... Unlike other antivirals that target the virus itself, the new ... that hepatitis C needs to replicate, the researchers explained. , ...
... , , CHICAGO, Dec. 3 ... medicine, called platelet-rich plasma therapy (PRP), is showing strong ... to a prominent dental researcher and editor of the ... James Rutkowski, DMD, PhD, reported at the recent annual ...
... Deutsches rzteblatt International contains the first scientific presentation ... virus (H1N1/09) in the German-speaking countries since the start ... the Dsseldorf University Hospital retrospectively evaluated data from a ... Dtsch Arztebl Int 2009; 106[47]: 770-6). Their medical-scientific ...
Cached Medicine News:Health News:Centegra H1N1 Vaccination Clinics Continue 2Health News:Centegra H1N1 Vaccination Clinics Continue 3Health News:Centegra H1N1 Vaccination Clinics Continue 4Health News:Salk Institute Board of Trustees Elects Leaders in Venture Capital and Publishing to its Membership 2Health News:Wayne State Researchers Report a Possible 'Proofreading' Step in DNA Synthesis by Observing Single Molecules of DNA Polymerase 2Health News:Wayne State Researchers Report a Possible 'Proofreading' Step in DNA Synthesis by Observing Single Molecules of DNA Polymerase 3Health News:New Hepatitis C Treatment Shows Promise 2Health News:New Hepatitis C Treatment Shows Promise 3Health News:Platelet-rich Plasma Enhances Bone and Tissue Growth for Dental Implants 2
(Date:5/27/2015)... The Bio-Process Systems Alliance (BPSA) is pleased ... (ISUS 2015) will be held July 13-15, 2015, ... primary focus on the promises and hurdles impacting the ... to business and regulatory presentations, ISUS 2015 will examine ... single-use industry as the "go-to" platform in bioprocessing. The ...
(Date:5/27/2015)... Manitoba , May 27, 2015 ... customers, the Canadian International Pharmacy Association (CIPA) ... medications online from licensed Canadian pharmacies. Approximately 64% of ... maintenance medications from a non-U.S. pharmacy due to ... are not covered under their insurance plan.   ...
(Date:5/27/2015)... ANGELES , May 27, 2015  CytRx Corporation ... company specializing in oncology, today announced an upcoming poster ... 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, ... 2015 in Chicago . ... profile we,re seeing in patients who have undergone treatment ...
Breaking Medicine Technology:BPSA's 5th Annual Summit to Provide '2020 Vision' for Single-Use Technologies 2BPSA's 5th Annual Summit to Provide '2020 Vision' for Single-Use Technologies 3Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 2Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 3CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 2CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 3CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 4CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 5
... WIRE)--Jun 27, 2007 - Annals of,Internal Medicine has ... the impact of genistein on bone loss. The ... in Osteopenic,Postmenopausal Women-A Randomized Trial," appears in the ... and efficacy of,genistein for the dietary management of ...
... - Opexa,Therapeutics, Inc. (NASDAQ:OPXA), a company involved ... presented,poster presentations at the 5th International Society ... Cairns, Queensland, Australia,from June 17-20 and at ... for Cellular Therapy (ISCT) in Sydney, Australia ...
Cached Medicine Technology:New Proof of Genistein's Efficacy and Safety for Osteopenia and,Osteoporosis Published in Annals of Internal Medicine 2New Proof of Genistein's Efficacy and Safety for Osteopenia and,Osteoporosis Published in Annals of Internal Medicine 3Opexa Advances Monocyte Derived Islet Technology to Proof of,Principle in stz-induced NOD/SCID Mice 2Opexa Advances Monocyte Derived Islet Technology to Proof of,Principle in stz-induced NOD/SCID Mice 3
... First Stop absorbable collagen hemostat. FirstStop is ... handling and removal characteristics. It can easily ... fit the wound. FirstStop products are not ... peeled away after hemostasis is achieved. As ...
InterVascular HemaCarotid Patch product line offers the vascular surgeon a complete range of knitted, collagen coated patches in a wide range of sizes for carotid endarterectomy and angioplasty witho...
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
Medicine Products: